Conduit Pharmaceuticals (CDT) News Today → The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad) Free CDT Stock Alerts $3.09 +0.12 (+4.04%) (As of 05/13/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 4, 2024 | americanbankingnews.comConduit Pharmaceuticals (NASDAQ:CDT) Stock Price Up 0.3%April 12, 2024 | marketbeat.comConduit Pharmaceuticals Inc. (NASDAQ:CDT) Sees Significant Decrease in Short InterestConduit Pharmaceuticals Inc. (NASDAQ:CDT - Get Free Report) was the recipient of a significant decrease in short interest in March. As of March 31st, there was short interest totalling 55,100 shares, a decrease of 29.2% from the March 15th total of 77,800 shares. Currently, 0.5% of the shares of the company are short sold. Based on an average daily volume of 39,800 shares, the days-to-cover ratio is currently 1.4 days.April 1, 2024 | marketbeat.comConduit Pharmaceuticals Inc. (NASDAQ:CDT) Short Interest Up 12.8% in MarchConduit Pharmaceuticals Inc. (NASDAQ:CDT - Get Free Report) was the recipient of a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 77,800 shares, a growth of 12.8% from the February 29th total of 69,000 shares. Currently, 0.8% of the shares of the company are sold short. Based on an average daily volume of 43,400 shares, the days-to-cover ratio is currently 1.8 days.March 19, 2024 | finance.yahoo.comConduit Pharmaceuticals Adds Key Leadership PositionsMarch 19, 2024 | globenewswire.comConduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific OfficerMarch 14, 2024 | marketbeat.comShort Interest in Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Decreases By 39.1%Conduit Pharmaceuticals Inc. (NASDAQ:CDT - Get Free Report) saw a large drop in short interest during the month of February. As of February 29th, there was short interest totalling 69,000 shares, a drop of 39.1% from the February 14th total of 113,300 shares. Based on an average daily trading volume, of 98,800 shares, the days-to-cover ratio is presently 0.7 days. Approximately 0.7% of the shares of the company are sold short.March 11, 2024 | finance.yahoo.comConduit Pharmaceuticals Opens New Laboratory in UKMarch 11, 2024 | finance.yahoo.comConduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences HubMarch 11, 2024 | globenewswire.comConduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe's Leading Life Sciences HubMarch 3, 2024 | marketbeat.comShort Interest in Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Declines By 13.2%Conduit Pharmaceuticals Inc. (NASDAQ:CDT - Get Free Report) was the target of a significant decrease in short interest during the month of February. As of February 15th, there was short interest totalling 113,300 shares, a decrease of 13.2% from the January 31st total of 130,500 shares. Approximately 1.1% of the company's shares are short sold. Based on an average trading volume of 148,400 shares, the days-to-cover ratio is presently 0.8 days.February 28, 2024 | seekingalpha.comConduit Pharmaceuticals: Stellar Management Team, New Business ModelFebruary 23, 2024 | marketbeat.comConduit Pharmaceuticals (NASDAQ:CDT) Trading 6.8% Higher Conduit Pharmaceuticals (NASDAQ:CDT) Trading Up 6.8%February 15, 2024 | sg.finance.yahoo.comConduit Pharmaceuticals Inc. (CDT)February 13, 2024 | uk.finance.yahoo.comConduit Pharmaceuticals Inc. (CDTTW)January 31, 2024 | finance.yahoo.comConduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceDecember 13, 2023 | marketbeat.comTrading was temporarily halted for "CDT" at 11:12 AM with a stated reason of "LULD pause."December 8, 2023 | marketbeat.comTrading was temporarily halted for "CDT" at 10:12 AM with a stated reason of "LULD pause."December 8, 2023 | marketbeat.comTrading was temporarily halted for "CDT" at 10:12 AM with a stated reason of "LULD pause."December 6, 2023 | wsj.comConduit Pharmaceuticals Inc.November 30, 2023 | marketbeat.comTrading was temporarily halted for "CDT" at 09:11 AM with a stated reason of "LULD pause."November 29, 2023 | marketbeat.comTrading was temporarily halted for "CDT" at 03:11 PM with a stated reason of "LULD pause."November 29, 2023 | marketbeat.comTrading was temporarily halted for "CDT" at 10:11 AM with a stated reason of "LULD pause."November 2, 2023 | finance.yahoo.comConduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare ConferenceOctober 31, 2023 | msn.comKXIN and ICU among pre-market losersOctober 28, 2023 | seekingalpha.comCDT Conduit Pharmaceuticals Inc.October 24, 2023 | uk.investing.comConduit Pharmaceuticals Inc (CDT)October 11, 2023 | finance.yahoo.comConduit Pharma CEO Tapolczay on Biopharma Differentiation, PipelineOctober 11, 2023 | finance.yahoo.comConduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656October 4, 2023 | marketbeat.comTrading was temporarily halted for "CDT" at 10:10 AM with a stated reason of "LULD pause."October 4, 2023 | marketbeat.comTrading was temporarily halted for "CDT" at 10:10 AM with a stated reason of "LULD pause." Trading set to resume at 10:10 AM. October 4, 2023 | marketbeat.comTrading was temporarily halted for "CDT" at 10:10 AM with a stated reason of "LULD pause." Trading set to resume at 10:10 AM. October 4, 2023 | marketbeat.comTrading was temporarily halted for "CDT" at 09:10 AM with a stated reason of "LULD pause." Get Conduit Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CDT and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon Musk’s Next Move Will Disrupt AI Forever (Ad)A revolutionary venture that is set to get rolled out by May 16. One well-connected Silicon Valley VC has uncovered a way for anybody to claim a stake in "Elon Musk's AI 2.0" with as little as $100. Get all the information here. CDT Media Mentions By Week CDT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CDT News Sentiment▼1.890.58▲Average Medical News Sentiment CDT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CDT Articles This Week▼11▲CDT Articles Average Week Get Conduit Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CDT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Zevra Therapeutics News G1 Therapeutics News Puma Biotechnology News Generation Bio News 23andMe News Merrimack Pharmaceuticals News AC Immune News Atossa Therapeutics News Eliem Therapeutics News Galectin Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CDT) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Conduit Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.